IntraOp is pleased to announce its participation in the upcoming ESTRO 2023 conference to be held in Vienna, May 12-16th.
If you are attending ESTRO this year, we would welcome the opportunity to schedule an in-person demo, or visit us at Booth 480, and let’s discuss what makes FLASH Radiotherapy* such a promising modality when clinical treatment becomes a reality.
First in FLASH. Future is Now.
The IntraOp Mobetron is the only electron UHDR device approved for FLASH clinical trials. It’s the first and most advanced platform for delivering ultra-high dose rate radiotherapy with electrons. Simply put, this is the de-facto system for electron FLASH clinical trials worldwide.
*Ultra-High Dose Rate (UHDR) functionality for FLASH Radiotherapy is for preclinical and investigational use only and is not approved for routine clinical use.